CH408950A - Verfahren zur Herstellung von basischen Thymyläthern - Google Patents

Verfahren zur Herstellung von basischen Thymyläthern

Info

Publication number: CH408950A
Authority: CH; Switzerland
Prior art keywords: thymyl; ethers; ether; ethyl; basic
Prior art date: 1960-07-26

Application number

CH804361A

Other languages

German (de)

English (en)

Inventor

Renwanz Gerhard Ing Dr

Karl Dr Med Credner

Geisel Berthold

Engelhard Hermann Prof Ing Dr

Original Assignee

Diwag Chemische Fabriken Aktie

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1960-07-26

Filing date

1961-07-10

Publication date

1966-03-15

1961-07-10 Application filed by Diwag Chemische Fabriken Aktie filed Critical Diwag Chemische Fabriken Aktie

1966-03-15 Publication of CH408950A publication Critical patent/CH408950A/de

Links

-1 thymyl ethers Chemical class 0.000 title claims description 14
238000000034 method Methods 0.000 title claims description 8
238000004519 manufacturing process Methods 0.000 title description 2
FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 10
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
239000002253 acid Substances 0.000 claims description 7
JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 claims description 6
150000003840 hydrochlorides Chemical class 0.000 claims description 5
150000003839 salts Chemical class 0.000 claims description 5
LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
150000001649 bromium compounds Chemical class 0.000 claims description 4
AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 claims description 4
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
239000011230 binding agent Substances 0.000 claims description 3
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 3
229910052794 bromium Inorganic materials 0.000 claims description 3
229910052801 chlorine Inorganic materials 0.000 claims description 3
239000000460 chlorine Substances 0.000 claims description 3
238000010438 heat treatment Methods 0.000 claims description 3
230000002035 prolonged effect Effects 0.000 claims description 3
239000002904 solvent Substances 0.000 claims description 3
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 2
150000007513 acids Chemical class 0.000 claims description 2
125000004423 acyloxy group Chemical group 0.000 claims description 2
125000003545 alkoxy group Chemical group 0.000 claims description 2
238000009833 condensation Methods 0.000 claims description 2
230000005494 condensation Effects 0.000 claims description 2
229910052736 halogen Inorganic materials 0.000 claims description 2
150000002367 halogens Chemical class 0.000 claims description 2
125000004356 hydroxy functional group Chemical group O* 0.000 claims description 2
238000002360 preparation method Methods 0.000 claims description 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 38
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 24
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 24
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 11
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
150000001298 alcohols Chemical class 0.000 description 9
150000001875 compounds Chemical class 0.000 description 6
239000000843 powder Substances 0.000 description 6
239000000243 solution Substances 0.000 description 6
238000006243 chemical reaction Methods 0.000 description 5
238000002844 melting Methods 0.000 description 5
230000008018 melting Effects 0.000 description 5
239000003208 petroleum Substances 0.000 description 5
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 4
230000000694 effects Effects 0.000 description 4
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
238000009835 boiling Methods 0.000 description 3
FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
230000001476 alcoholic effect Effects 0.000 description 2
239000003513 alkali Substances 0.000 description 2
238000001816 cooling Methods 0.000 description 2
238000000354 decomposition reaction Methods 0.000 description 2
239000000706 filtrate Substances 0.000 description 2
XTEGVFVZDVNBPF-UHFFFAOYSA-N naphthalene-1,5-disulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1S(O)(=O)=O XTEGVFVZDVNBPF-UHFFFAOYSA-N 0.000 description 2
229960002748 norepinephrine Drugs 0.000 description 2
SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 2
229940072033 potash Drugs 0.000 description 2
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
235000015320 potassium carbonate Nutrition 0.000 description 2
HFRXJVQOXRXOPP-UHFFFAOYSA-N thionyl bromide Chemical compound BrS(Br)=O HFRXJVQOXRXOPP-UHFFFAOYSA-N 0.000 description 2
125000003639 thymyl group Chemical group C1(=CC(C)=CC=C1C(C)C)* 0.000 description 2
230000003313 weakening effect Effects 0.000 description 2
XGIKILRODBEJIL-UHFFFAOYSA-N 1-(ethylamino)ethanol Chemical compound CCNC(C)O XGIKILRODBEJIL-UHFFFAOYSA-N 0.000 description 1
HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
206010020772 Hypertension Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
240000005578 Rivina humilis Species 0.000 description 1
239000000219 Sympatholytic Substances 0.000 description 1
230000000397 acetylating effect Effects 0.000 description 1
239000003929 acidic solution Substances 0.000 description 1
230000002908 adrenolytic effect Effects 0.000 description 1
150000001447 alkali salts Chemical class 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
230000036772 blood pressure Effects 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
150000002170 ethers Chemical class 0.000 description 1
UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
150000003947 ethylamines Chemical class 0.000 description 1
238000007038 hydrochlorination reaction Methods 0.000 description 1
IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
229910000041 hydrogen chloride Inorganic materials 0.000 description 1
239000012442 inert solvent Substances 0.000 description 1
229910052744 lithium Inorganic materials 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
239000011976 maleic acid Substances 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
150000007530 organic bases Chemical class 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
239000000376 reactant Substances 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
238000007127 saponification reaction Methods 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
235000009518 sodium iodide Nutrition 0.000 description 1
GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
125000001424 substituent group Chemical group 0.000 description 1
230000000948 sympatholitic effect Effects 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1

Landscapes

Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

CH804361A 1960-07-26 1961-07-10 Verfahren zur Herstellung von basischen Thymyläthern CH408950A (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DED33859A DE1153764B (de)	1960-07-26	1960-07-26	Verfahren zur Herstellung von basischen Thymylaethern

Publications (1)

Publication Number	Publication Date
CH408950A true CH408950A (de)	1966-03-15

Family

ID=7041922

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CH804361A CH408950A (de)	1960-07-26	1961-07-10	Verfahren zur Herstellung von basischen Thymyläthern

Country Status (4)

Country	Link
CH (1)	CH408950A (da)
DE (1)	DE1153764B (da)
DK (1)	DK105276C (da)
FR (1)	FR1664M (da)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH294504A (fr) *	1949-06-08	1953-11-15	Smith Kline & French Internati	Procédé de préparation d'un sel d'une halo-amine tertiaire.

1960
- 1960-07-26 DE DED33859A patent/DE1153764B/de active Pending
1961
- 1961-07-10 CH CH804361A patent/CH408950A/de unknown
- 1961-07-26 DK DK306361A patent/DK105276C/da active
- 1961-10-20 FR FR868731A patent/FR1664M/fr not_active Expired

Also Published As

Publication number	Publication date
DE1153764B (de)	1963-09-05
DK105276C (da)	1966-09-12
FR1664M (fr)	1963-01-21

Publication	Publication Date	Title
CH395136A (de)	1965-07-15	Verfahren zur Herstellung von Xanthenen oder Thiaxanthenen
DE1593579B1 (de)	1972-02-03	Hydroxy-cyclohexylamine,deren physiologisch vertraeglichen Saeureadditionssalze und Verfahren zu ihrer Herstellung
DE1518207B1 (de)	1971-07-01	Verfahren zur Herstellung von neuen Phenylcyclopropanderivaten bzw. deren Salzen und quaternaeren Ammoniumverbindungen
DE2818403A1 (de)	1979-11-08	Neue isochinolinderivate und verfahren zu ihrer herstellung
DE2631222A1 (de)	1978-01-19	Verfahren zur herstellung basisch substituierter phenylacetonitrile
DE2351281C3 (de)	1981-07-30	Aminophenyl-äthanolamin-Derivate, deren Herstellung und Verwendung
DE1103342B (de)	1961-03-30	Verfahren zur Herstellung neuer 1, 2-Diphenyl-3, 5-dioxo-1, 2, 4-triazolidin-Derivate
CH408950A (de)	1966-03-15	Verfahren zur Herstellung von basischen Thymyläthern
DE1643317A1 (de)	1971-06-16	Basische Phenoxy-acetamide und Verfahren zu ihrer Herstellung
AT202152B (de)	1959-02-10	Verfahren zur Herstellung von neuen Dimethylaminopropylidenthiaxanthenen.
AT231429B (de)	1964-01-27	Verfahren zur Herstellung von neuen basischen Thymyläthern und ihren Salzen
AT202143B (de)	1959-02-10	Verfahren zur Herstellung von neuen Dimethylaminopropylidenxanthenen
DE2736106A1 (de)	1978-02-23	Neuartige aryloxy-1-amino-3-propanole-2, verfahren zum herstellen und therapeutische anwendung derselben
AT215424B (de)	1961-06-12	Verfahren zur Herstellung von Xanthenen bzw. Thiaxanthenen
AT233538B (de)	1964-05-11	Verfahren zur Herstellung von neuen Farnesylverbindungen
DE1543185A1 (de)	1969-07-31	Acylphenole und Verfahren zu deren Herstellung
AT118738B (de)	1930-08-11	Verfahren zur Darstellung N-substituierter Aminochinoline.
DE544087C (de)	1932-02-13	Verfahren zur Darstellung aromatischer N-Dialkylaminoalkylaminoaldehyde und ihrer Derivate
AT206439B (de)	1959-11-25	Verfahren zur Herstellung von neuen, racemischen oder optisch aktiven Piperidyl-(2)-arylmethanoläthern
DE1620206C (de)	1972-10-12	N-Cyclopropylmethyl-6,14-endo-äthanotetrahydronororipavine und ihre Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
AT234691B (de)	1964-07-10	Verfahren zur Herstellung von neuen Piperidinderivaten
AT251565B (de)	1967-01-10	Verfahren zur Herstellung von neuen Carbonsäuren
AT274806B (de)	1969-10-10	Verfahren zur Herstellung von in 2-Stellung substituierten 1,3-Diazacyclopentenen-(2)
AT338266B (de)	1977-08-10	Verfahren zur herstellung von neuen substituierten phenylalkanol-derivaten und ihren saureadditionssalzen
AT201584B (de)	1959-01-10	Verfahren zur Herstellung neuer Anilide und deren Salze